Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

4.17USD
24 Oct 2014
Price Change (% chg)

$0.07 (+1.71%)
Prev Close
$4.10
Open
$4.12
Day's High
$4.18
Day's Low
$4.10
Volume
662,453
Avg. Vol
1,154,739
52-wk High
$7.97
52-wk Low
$3.26

ARNA.OQ

Chart for ARNA.OQ

About

Arena Pharmaceuticals, Inc. (Arena) is a biopharmaceutical company focused on discovering, developing and commercializing drugs that target G protein-coupled receptors. Its wholly owned subsidiary, Arena Pharmaceuticals GmbH (Arena GmbH), has granted Eisai Inc., rights to commercialize BELVIQ in the United States. The Company’s... (more)

Overall

Beta: -0.41
Market Cap (Mil.): $916.72
Shares Outstanding (Mil.): 219.84
Dividend: --
Yield (%): --

Financials

  ARNA.OQ Industry Sector
P/E (TTM): -- 161.00 34.06
EPS (TTM): -0.27 -- --
ROI: -22.27 -1.64 17.45
ROE: -51.31 -6.68 18.26
Search Stocks

Competitors

  Price Change
Novo Nordisk A/S (NOVOb.CO) kr.267.10 -2.40
Roche Holding Ltd. (ROG.VX) CHF278.00 -1.40
GlaxoSmithKline plc (GSK.L) 1,415.50p +3.50
VIVUS, Inc. (VVUS.OQ) $3.41 +0.01
Orexigen Therapeutics, Inc. (OREX.OQ) $4.39 +0.01

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks